Prognostic value of oral candidosis and hairy leukoplakia in 111 Mexican HIV-infected patients

Journal of Oral Pathology and Medicine

Volumn 25, Issue 5, 1996, Pages 206-211

  Ramírez Amador, Velia A ^a   Esquivel Pedraza, Lilly ^a   Ponce De Leon, Sergio ^b   Ponce De Leon, Samuel ^b  

^a DEPARTAMENTO DE SISTEMAS BIOLÓGICOS   (Mexico)

^b INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

AIDS; Hairy leukoplakia; HIV infection; Oral candidosis; Prognosis; Survival analysis

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AIDS RELATED COMPLEX; ANALYSIS OF VARIANCE; ARTICLE; CLASSIFICATION; COHORT ANALYSIS; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOPLAKIA; LYMPHOCYTE COUNT; MALE; MEXICO; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; STATISTICAL MODEL; THRUSH;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANALYSIS OF VARIANCE; ANTI-HIV AGENTS; CANDIDIASIS, ORAL; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; LEUKOPLAKIA, HAIRY; LINEAR MODELS; LYMPHOCYTE COUNT; MALE; MEXICO; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; ZIDOVUDINE;

EID: 0030136181     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0714.1996.tb01373.x     Document Type: Article

References (45)

1. FEIGAL DW, KATZ MH, GREENSPAN D, et al. The prevalence of oral lesions in HIV-infected homosexual and bisexual men: three San Francisco epidemiological cohorts. AIDS 1991; 5: 519-25.
2. LIFSON AR, HILTON JF, WESTENHOUSE JL, et al. Time from HIV seroconversion to oral candidiasis or hairy leukoplakia among homosexual and bisexual men enrolled in three prospective cohorts. AIDS 1994; 8: 73-9.
3. KATZ MH, GREENSPAN D, WESTENHOUSE J, et al. Progression to AIDS in HIV-infected homosexual and bisexual men with hairy leukoplakia and oral candidiasis. AIDS 1992; 6: 95-100.
4. GREENSPAN JS, GREENSPAN D. Oral hairy leukoplakia: diagnosis and management. Oral Surg Oral Med Oral Pathol 1989; 67: 396-403.
5. SCIUBBA J, BRANDSMA J, SCHWARTZ M, BARREZUETA N. Hairy leukoplakia: an AIDS-associated opportunistic infection. Oral Surg Oral Med Oral Pathol 1989; 67: 404-10.
6. LAMSTER IB, BEGG MD, MITCHEL-LEWIS D, et al. Oral manifestations of HIV infection in homosexual men and intravenous drug users. Study design and relationship of epidemiologic, clinical, and immunologic parameters to oral lesions. Oral Surg Oral Med Oral Pathol 1994; 78: 163-74.
7. BARR CE, LOPEZ MR, RUA-DOBLES A, MILLER LK, MATHUR-WAGH U, TURGEON LR. HIV-associated oral lesions: immunologic, virologic and salivary parameters. J Oral Pathol Med 1992; 21: 295-8.
8. THOMPSON SH, CHARLES GA, CRAIG DB. Correlation of oral disease with the Walter Reed staging scheme for HIV-1 seropositive patients. Oral Surg Oral Med Oral Pathol 1992; 73: 289-92.
9. KOLOKOTRONIS A, KIOSES V, ANTONIADES D, MANDRAVELI K, DOUTSOS I, PAPANAYOTOU P. Immunologic status in patients infected with HIV with oral candidiasis and hairy leukoplakia. Oral Surg Oral Med Oral Pathol 1994; 78: 41-6.
10. SAAH AJ, MUÑOz A, KUO V, et al. Predictors of the risk of development of acquired immunodeficiency syndrome within 24 months among gay men seropositive for human immunodeficiency virus type 1: a report from the Multicenter AIDS Cohort Study. Am J Epidemiol 1992; 135: 1147-55.
11. KLEIN RS, HARRIS CA, SMALL CB, MOLL B, LESSER M, FRIEDLAND GH. Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N Engl J Med 1984; 311: 354-8.
12. GREENSPAN D, GREENSPAN JS, HEARST NG, et al. Relation of oral hairy leukoplakia to infection with the human immunodeficiency virus and the risk of developing AIDS. J Infec Dis 1987; 155: 475-81.
13. MORFELDT-MANSON L, JULANDER I, NILSSON B. Dermatitis of the face, yellow toe nail changes, hairy leukoplakia and oral candidiasis are clinical indicators of progression to AIDS/opportunistic infection in patients with HIV infection. Scand J Infect Dis 1989; 21: 497-505.
14. FISCHL MA, RICHMAN DD, HANSEN N, et al. The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. Ann Intern Med 1990; 112: 727-37.
15. MONIACI D, GRECO D, FLECCHIA G, RAITERI R, SINICCO A. Epidemiology, clinical features and prognostic value of HIV-1 related oral lesions. J Oral Pathol Med 1990; 19: 477-81.
16. KAPLAN JE, SPIRA TJ, FISHBEIN DB, LYNN HS. Ten-year follow-up of HIV-infected homosexual men with lymphadenopathy syndrome: evidence for continuing risk of developing AIDS. J AIDS 1992; 5: 565-70.
17. SELWYN PA, ALCABES P, HARTEL D, et al. Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection. N Engl J Med 1992; 327: 1697-703.
18. GILLESPIE G, MARINO R. Oral manifestations of the human immunodeficiency virus infection: a Panamerican perspective. J Oral Pathol Med 1993; 22: 2-7.
19. Centers for Disease Control. Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections. MMWR 1986; 35: 334-9.
20. EEC-CLEARINGHOUSE on Oral Problems Related To HIV Infection and WHO Collaborating Centre on Oral Manifestations of the Immunodeficiency Virus. An update of the classification and diagnostic criteria for oral lesions in HIV infection. J Oral Pathol Med 1991; 20: 97-100.
21. EC-Clearinghouse on Oral Problems Related To HIV Infection and WHO Collaborating Centre on Oral Manifestations of the Immunodeficiency Virus. Classification and diagnostic criteria for oral lesions in HIV infection. J Oral Pathol Med 1993; 22: 289-91.
22. DODD CL, GREENSPAN D, KATZ MH, WESTENHOUSE JL, FEIGAL DW, GREENSPAN JS. Oral candidiasis in HIV infection: pseudomembranous and erythematous candidiasis show similar rates of progression to AIDS. AIDS 1991; 5: 1339-43.
23. NIELSEN H, BENTSEN KD, HOJTVED L, et al. Oral candidiasis and immune status of HIV-infected patients. J Oral Pathol Med 1994; 23: 140-3.
24. SCHULTEN EAJM, SNIJDERS PJF, TEN KATE RW, et al. Oral hairy leukoplakia in HIV infection: a diagnostic pitfall. Oral Surg Oral Med Oral Pathol 1991; 71: 32-7.
25. Centers for Disease Control. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 1987; 36 (suppl. 1): 3S-15S.
26. ARMITAGE P, BERRY G. Statistical methods in medical research. Oxford, Blackwell Scientific Publications. 1987
27. KAHN HA, SEMPOS CT. Statistical methods in epidemiology. New York: Oxford University Press, 1989.
28. Computing Resource Center, Stata. Version 3.0. CRC. 1640 Fifth Street, Santa Monica, CA, 90401. USA.
29. Institute Nacional de Diagnostico y Referenda Epidemiologicos. Boletin Mensual de SIDA/ETS (Mexico) 1995; 1: 1-16.
30. RAMÍREZ-AMADOR V, REYES-TERAN G, PONCE-DE-LEÓN S, PONCE-DE-LEÓN S. Oral lesions of HIV-infection in Mexico City. In: Greenspan JS, Greenspan D, ed. Oral manifestations of HIV infection. Quintessence Publishing Co, 1995; 73-9.
31. SCHULTEN EAJM, TEN KATE RW, VAN DER WAAL I. Oral manifestations of HIV infection in 75 Dutch patients. J Oral Pathol Med 1989; 18: 42-6.
32. WANZALA P, MANJI F, PINDBORG JJ, PLUMMER F. Low prevalence of oral mucosal lesions in HIV-I seropositive African women. J Oral Pathol Med 1989; 18: 416-8.
33. Centers for Disease Control. Recommendations for prophylaxis against Pneumocystis carinii pneumonia for adults and adolescents infected with human immunodeficiency virus. MWWR 1992; 41(RR-4): 1-11.
34. KIRBY AJ, MUÑOZ A, DETELS R, ARMSTRONG JA, SAAH A, PHAIR JP. Trush and fever as measures of immunocompetence in HIV-1-infected men. J AIDS 1994; 7: 1242-49.
35. MOSS AR, BACCHETTI P, OSMOND D, et al. Seropositivity for HIV and the development of AIDS or AIDS-related condition: three-year follow-up of the San Francisco General Hospital cohort. BMJ 1988; 296: 745-50.
36. World Health Organization. Acquired immune deficiency syndrome (AIDS) interim proposal for a WHO staging system for HIV infection and disease. Wkly Epidemiol Rec 1990; 65: 221-8.
37. MONTANER JSG, LE TN, LE N, CRAIB KJP, SCHECHTER MT. Application of the World Health Organization system for HIV infection in a cohort of homosexual men in developing a prognostically meaningful staging system. AIDS 1992; 6: 719-24.
38. BLATT SP, LUCEY CR, BUTZIN CA, HENDRIX CW, LUCEY DR. Total lymphocyte count as a predictor of absolute CD4+ percentage in HIV-infected persons. JAMA 1993; 269: 622-6
39. Fahey JL, Taylor JMG, Detels R, et al. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. N Engl J Med 1990; 322: 166-72.
40. BURCHAM J, MARMOR M, DUBIN N, et al. CD4% is the best predictor of development of AIDS in a cohort of HIV-infected homosexual men. AIDS 1991; 5: 365-72.
41. CHOI S, LAGAKOS SW, SCHOOLEY RT, VOLBERDING PA. CD4+ lymphocytes are an incomplete surrogate marker for clinical progression in persons with asymptomatic HIV infection taking zidovudine. Ann Intern Med 1993; 118: 674-80.
42. TAYLOR JMG, FAHEY JL, DETELS R, GIORGI J. CD4 percentage, CD4 number, and CD4 ratio in HIV infection: which to choose and how to use. J AIDS 1989; 2: 114-24.
43. REYES-TERAN G, PONCE DE LEÓN S. Conteo de celulas T CD4+ y su uso en el manejo de pacientes con HIV-1. Rev Invest Clin (Mexico) 1993; 45: 363-70.
44. HOOVER DM, GRAHAM NMH, CHEN B, et al. Effect of CD4+ cell count measurement variability on staging HIV-1 infection. J AIDS 1992; 5: 794-802.
45. COHEN J. Searching for markers on the AIDS trail. Science 1992; 258: 388-90.